Cell-ebrating the dosing of patients with jCell in a phase 2 clinical trial for RP
The latest research news from Retina UK.
Search
Search results
Opus Genetics – the next BEST thing!
The latest research news from Retina UK.
Belite Bio – Phase 2/3 Trial for Adolescents with Stargardt disease
The latest research news piece from Retina UK.
Retina-on-a-chip: the tiny technology offering big hope for inherited sight loss
Researchers in the Netherlands are developing a “retina-on-a-chip” that mimics the key layers of the human retina, offering a powerful new way to study inherited retinal diseases (IRDs) and test potential treatments using human cells.
PDE6A gene therapy trial report: the importance of scientific learnings in an unsuccessful trial
Researchers from the University Hospital Tübingen in Germany recently announced that there were no signs of visual gains in an early-phase clinical trial of a PDE6A gene therapy for Retinitis Pigmentosa (RP).
Meet our community: Russ Stephenson
Russ was diagnosed with Choroideremia at the age of 11, after visiting caves in Spain and not being able to see anything.
e-Newsletter January 2024
Our monthly e-Newsletter featuring the latest updates from Retina UK. Subscribe now to receive these updates directly to your email.
QAC Sight Village: North East
An unmissable event for people of all ages living with varying degrees of sight loss, professionals supporting and advising VIP's and for all businesses and other organisations wishing to improve their services for the visually impaired.
QAC Sight Village: Central – Eastside Rooms
An unmissable event for people of all ages living with varying degrees of sight loss, professionals supporting and advising VIP’s and for all businesses and other organisations wishing to improve their services for the visually impaired.
QAC Sight Village: Wales
An unmissable event for people of all ages living with varying degrees of sight loss, professionals supporting and advising VIP’s and for all businesses and other organisations wishing to improve their services for the visually impaired.